HRP20200426T1 - Postupak za pripremu 1-(4-(4-(3,4-dikloro-2-fluorofenilamino)-7-metoksikinazolin-6-iloksi)piperi din-1-il)-prop-2-en-1-on hidroklorida i posrednici koji se koriste - Google Patents

Postupak za pripremu 1-(4-(4-(3,4-dikloro-2-fluorofenilamino)-7-metoksikinazolin-6-iloksi)piperi din-1-il)-prop-2-en-1-on hidroklorida i posrednici koji se koriste Download PDF

Info

Publication number
HRP20200426T1
HRP20200426T1 HRP20200426TT HRP20200426T HRP20200426T1 HR P20200426 T1 HRP20200426 T1 HR P20200426T1 HR P20200426T T HRP20200426T T HR P20200426TT HR P20200426 T HRP20200426 T HR P20200426T HR P20200426 T1 HRP20200426 T1 HR P20200426T1
Authority
HR
Croatia
Prior art keywords
formula
compound
image
group
mixture
Prior art date
Application number
HRP20200426TT
Other languages
English (en)
Croatian (hr)
Inventor
Keuk Chan Bang
Young Ho Moon
Young Kil Chang
Original Assignee
Hanmi Science Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48044309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20200426(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Science Co., Ltd. filed Critical Hanmi Science Co., Ltd.
Publication of HRP20200426T1 publication Critical patent/HRP20200426T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HRP20200426TT 2011-10-05 2012-10-05 Postupak za pripremu 1-(4-(4-(3,4-dikloro-2-fluorofenilamino)-7-metoksikinazolin-6-iloksi)piperi din-1-il)-prop-2-en-1-on hidroklorida i posrednici koji se koriste HRP20200426T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020110101422A KR101272613B1 (ko) 2011-10-05 2011-10-05 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온 염산염의 제조 방법 및 이에 사용되는 중간체
PCT/KR2012/008077 WO2013051883A2 (en) 2011-10-05 2012-10-05 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein
EP12838558.0A EP2763981B1 (en) 2011-10-05 2012-10-05 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein

Publications (1)

Publication Number Publication Date
HRP20200426T1 true HRP20200426T1 (hr) 2020-09-04

Family

ID=48044309

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200426TT HRP20200426T1 (hr) 2011-10-05 2012-10-05 Postupak za pripremu 1-(4-(4-(3,4-dikloro-2-fluorofenilamino)-7-metoksikinazolin-6-iloksi)piperi din-1-il)-prop-2-en-1-on hidroklorida i posrednici koji se koriste

Country Status (23)

Country Link
US (1) US8859767B2 (enExample)
EP (2) EP3611172A1 (enExample)
JP (1) JP5805880B2 (enExample)
KR (1) KR101272613B1 (enExample)
CN (2) CN110003174A (enExample)
AU (1) AU2012319291B2 (enExample)
BR (1) BR112014007718B1 (enExample)
CA (1) CA2850055C (enExample)
CY (1) CY1122758T1 (enExample)
DK (1) DK2763981T3 (enExample)
ES (1) ES2775197T3 (enExample)
HR (1) HRP20200426T1 (enExample)
HU (1) HUE048798T2 (enExample)
IL (3) IL231911B (enExample)
IN (1) IN2014DN03447A (enExample)
LT (1) LT2763981T (enExample)
MX (1) MX348815B (enExample)
PL (1) PL2763981T3 (enExample)
PT (1) PT2763981T (enExample)
RS (1) RS60118B1 (enExample)
RU (1) RU2563630C1 (enExample)
SI (1) SI2763981T1 (enExample)
WO (1) WO2013051883A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101317809B1 (ko) 2011-06-07 2013-10-16 한미약품 주식회사 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko) * 2013-01-28 2014-08-06 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
CN104513229A (zh) * 2013-09-28 2015-04-15 正大天晴药业集团股份有限公司 喹唑啉衍生物及其制备方法
JP6704422B2 (ja) 2015-03-20 2020-06-03 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッドChia Tai Tianqing Pharmaceutical Group Co., Ltd. キナゾリン誘導体の塩およびその製造方法
KR102802129B1 (ko) * 2018-09-14 2025-05-02 한미약품 주식회사 퀴나졸린 화합물 및 이의 염산염의 결정 형태
KR101950942B1 (ko) * 2019-01-28 2019-02-22 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
US20210221792A1 (en) * 2020-01-16 2021-07-22 Hanmi Pharm Co., Ltd. Convergent synthesis of poziotinib derivative
WO2022043923A1 (en) * 2020-08-28 2022-03-03 Hanmi Science Co., Ltd. Synthesis of poziotinib derivative

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI324597B (en) * 2002-03-28 2010-05-11 Astrazeneca Ab Quinazoline derivatives
DE602004004811T2 (de) * 2003-09-19 2007-11-22 Astrazeneca Ab Chinazolinderivate
GB0322409D0 (en) * 2003-09-25 2003-10-29 Astrazeneca Ab Quinazoline derivatives
JP2009518450A (ja) * 2005-12-12 2009-05-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 二環式複素環化合物、その化合物を含む薬剤、その使用及び製造方法
TWI377944B (en) * 2007-06-05 2012-12-01 Hanmi Holdings Co Ltd Novel amide derivative for inhibiting the growth of cancer cells
US8450482B2 (en) * 2009-04-23 2013-05-28 Astrazeneca Ab Process for the preparation of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-([1-(N-methylcarbamoymethyl)piperidin-4-yl]oxy)quinazoline

Also Published As

Publication number Publication date
HUE048798T2 (hu) 2020-08-28
EP2763981A2 (en) 2014-08-13
LT2763981T (lt) 2020-05-25
ES2775197T3 (es) 2020-07-24
DK2763981T3 (da) 2020-03-16
JP2014528444A (ja) 2014-10-27
EP2763981B1 (en) 2020-01-08
CN103857672B (zh) 2018-11-30
JP5805880B2 (ja) 2015-11-10
WO2013051883A2 (en) 2013-04-11
CA2850055E (en) 2013-04-11
EP2763981A4 (en) 2015-02-25
CA2850055C (en) 2016-05-17
US20140275534A1 (en) 2014-09-18
CA2850055A1 (en) 2013-04-11
IL231911A0 (en) 2014-05-28
US8859767B2 (en) 2014-10-14
IN2014DN03447A (enExample) 2015-06-26
CN110003174A (zh) 2019-07-12
BR112014007718A2 (pt) 2017-04-25
RS60118B1 (sr) 2020-05-29
PT2763981T (pt) 2020-03-25
PL2763981T3 (pl) 2020-08-10
RU2563630C1 (ru) 2015-09-20
EP3611172A1 (en) 2020-02-19
IL259694A (en) 2018-07-31
BR112014007718B1 (pt) 2022-02-22
CY1122758T1 (el) 2021-03-12
MX2014003959A (es) 2014-05-14
CN103857672A (zh) 2014-06-11
IL291738A (en) 2022-05-01
WO2013051883A3 (en) 2013-06-06
IL231911B (en) 2018-06-28
SI2763981T1 (sl) 2020-07-31
KR20130037079A (ko) 2013-04-15
KR101272613B1 (ko) 2013-06-10
AU2012319291A1 (en) 2014-05-22
IL259694B (en) 2022-04-01
MX348815B (es) 2017-06-30
AU2012319291B2 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
HRP20200426T1 (hr) Postupak za pripremu 1-(4-(4-(3,4-dikloro-2-fluorofenilamino)-7-metoksikinazolin-6-iloksi)piperi din-1-il)-prop-2-en-1-on hidroklorida i posrednici koji se koriste
ES2587903T3 (es) Compuestos de imidazolidinadiona y sus usos
JP6050358B2 (ja) ベンゾオキサジノンをアミンと反応させることによるテトラゾール置換アントラニル酸ジアミド誘導体の製造方法
EP3059237A1 (en) Methods for preparing brexpiprazole, key intermediates thereof and salts thereof
JP2015524409A5 (enExample)
JP2015509939A5 (enExample)
EA201170098A1 (ru) Замещенные производные алкилпиримидин-4-она
JP7051929B2 (ja) １－（４－（４－（３，４－ジクロロ－２－フルオロフェニルアミノ）－７－メトキシキナゾリン－６－イルオキシ）ピペリジン－１－イル）プロパ－２－エン－１－オンの製造方法
JP2011510970A5 (enExample)
HRP20190720T1 (hr) Sinteza kopanlisiba i njegove dihidrokloridne soli
JP2014522385A5 (enExample)
WO2009154754A3 (en) Synthesis of deuterated morpholine derivatives
MX2010013939A (es) Derivados de n-oxido pirazina sustituidos.
HRP20210103T1 (hr) Postupak za proizvodnju spoja pirol0[3,2-d]pirimidina, kao i odgovarajućih intermedijera
JP2007507443A5 (enExample)
BR112018013249B1 (pt) Método de preparação de compostos de carboxilato depiridil pirazolidinona
JP2016503812A5 (enExample)
HRP20210376T1 (hr) Novi intermedijeri za pripremu remifentanil hidroklorida
CN105985317B (zh) 一种色瑞替尼的制备方法及其中间体
PL1999110T3 (pl) Sposób wytwarzania pochodnych 1-fluorowco-2,7-naftyrydynylowych
RU2015101339A (ru) Ксантиновое производное
HRP20170394T1 (hr) Postupak za sintezu 3,4-dimetoksibiciklo[4.2.0]okta-1,3,5-trien-7-karbonitrila i uporaba za sintezu ivabadina i njegovih adicijskih soli s farmacetuski prihvatljivom kiselinom
AR052864A1 (es) Preparacion de cetoamidas
HK40010388A (en) Preparation method for hydrochloride compound
TW201910313A (zh) 反式異構雜環化合物及其製備方法